zepbound vs glp 1 Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Medication Comparisons: Zepbound vs

The obesity drug sector, once stagnant, has exploded, with combined Novo Nordisk and Eli Lilly valuations exceeding $1 trillion

On the other hand, Mounjaro delivers even greater metabolic benefits, with studies showing up to 20% weight loss, making it a formidable contender for both diabetes and obesity treatment

Some monk fruit sweeteners are blended with other sweeteners like erythritol to balance taste and texture

Along with trademark issues and misleading marketing, Lilly, Novo Nordisk & their suite of lawyers are not fans of compounding either

McDonald, P

Important Drawbacks to Consider GLP-1s are not without downsides